文献速递MDS 与骨髓增殖性肿瘤

CALR突变通过增加活化血小板结合增强外周血淋巴细胞免疫抑制蛋白GARP和LAP的表达

The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets.
PubMed 文献 · Br J Haematol · 2024-08-20

研究检测56例骨髓增殖性肿瘤(MPN)患者和11名健康供者外周血淋巴细胞上免疫抑制分子LAP和GARP的表达,发现MPN患者淋巴细胞LAP和GARP表达升高,且CALR突变型MPN患者较健康供者和JAK2突变型患者表达更高,淋巴细胞与活化血小板结合比例与LAP和GARP表达强相关。

要点

  • MPN患者外周血淋巴细胞LAP和GARP表达高于健康供者,不同MPN诊断间无显著差异。
  • CALR突变型MPN患者淋巴细胞LAP和GARP表达高于健康供者和JAK2突变型患者。
  • 淋巴细胞与活化血小板结合比例与LAP和GARP表达强相关,提示活化血小板介导表达升高。

核心结论

  • MPN患者外周血淋巴细胞表达更高水平的LAP和GARP,CALR突变型患者较健康供者和JAK2突变型患者表达增加。
  • 淋巴细胞与活化血小板结合比例与LAP和GARP表达强相关,提示是活化血小板而非淋巴细胞本身赋予MPN患者淋巴细胞GARP和LAP表达增加。

研究设计与样本

  • 研究纳入56例MPN患者和11名健康供者(HD),检测外周血淋巴细胞上LAP和GARP的表达。
  • 分析临床参数对淋巴细胞LAP和GARP表达的影响,并分析血小板基因表达。

主要发现

  • MPN患者淋巴细胞LAP和GARP表达高于健康供者,不同MPN诊断之间未发现明显差异。
  • CALR突变型MPN患者淋巴细胞LAP和GARP表达高于健康供者和JAK2突变型患者。
  • 淋巴细胞与活化血小板结合比例与LAP和GARP表达强相关。
  • JAK2突变型与CALR突变型患者之间血小板计数和抗血栓治疗均无差异。
  • 血小板基因表达分析未发现JAK2突变型与CALR突变型患者之间相关基因表达存在差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently, an antibody which inhibits the glycoprotein A repetitions predominant (GARP)-mediated release of active transforming growth factor beta (TGFβ) from the TGFβ propeptide latency-associated peptide (LAP) showed preclinical activity in a murine model of the chronic myeloproliferative neoplasms (MPN). Consequently, we investigated the expression of the immunosuppressive molecules LAP and GARP on peripheral blood lymphocytes from 56 MPN patients and 11 healthy donors (HD). We found that lymphocytes from patients with MPN express higher levels of LAP and GARP with no strong differences found between the different MPN diagnoses. The impact of clinical parameters on the expression of LAP and GARP by lymphocytes showed that patients with calreticulin (CALR)mut MPN have increased expression compared with HD and patients with the Januskinase2 (JAK2) mutation. The fraction of lymphocytes bound to activated platelets (aPLT) strongly correlate to LAP and GARP expression suggesting that it is not the lymphocytes themselves but aPLT, which confer the increased expression of GARP and LAP on MPN patient lymphocytes. Notably, no differences in neither platelet counts nor anti-thrombotic therapy was identified between patients with JAK2- and CALRmut patients. Analysis of platelet gene expression failed to identify differences in expression of relevant genes between JAK2- and CALRmut patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Holmström MO, Ruders JH, Riley CH, et al. The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets. Br J Haematol. 2024. PMID: 39161981. doi:10.1111/bjh.19711

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。